• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶系统的研究。II. 血清或血浆对纤溶酶的抑制作用。

Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.

作者信息

NORMAN P S

出版信息

J Exp Med. 1958 Jul 1;108(1):53-68. doi: 10.1084/jem.108.1.53.

DOI:10.1084/jem.108.1.53
PMID:13549641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2136881/
Abstract

The inactivation of purified plasmin by serum or plasma was studied using a caseinolytic assay for determination of plasmin. On the basis of kinetic evidence, the presence of two inhibitors in normal human or guinea pig serum or plasma is suggested. The first reacts immediately at any temperature, but is easily dissociable and does not combine with plasmin in a fixed ratio. The second combines more slowly with plasmin at a rate which depends on temperature and on the concentration of both plasmin and inhibitor. There is a fixed ratio of reaction between plasmin and the second inhibitor and the combination does not readily dissociate. There is sufficient of the "slow" inhibitor in normal plasma to inactivate more than 30 times its own content of potential plasmin. The presence of suitable substrate for plasmin tends to reverse the combination with "immediate" inhibitor and to stop the further action of "slow" inhibitor.

摘要

使用酪蛋白溶解测定法测定纤溶酶,研究了血清或血浆对纯化纤溶酶的灭活作用。基于动力学证据,提示正常人或豚鼠血清或血浆中存在两种抑制剂。第一种在任何温度下都能立即反应,但很容易解离,且不以固定比例与纤溶酶结合。第二种与纤溶酶结合较慢,其速率取决于温度以及纤溶酶和抑制剂的浓度。纤溶酶与第二种抑制剂之间存在固定的反应比例,且这种结合不易解离。正常血浆中存在足够的“慢”抑制剂,可使超过其自身潜在纤溶酶含量30倍的纤溶酶失活。纤溶酶合适底物的存在往往会逆转与“即时”抑制剂的结合,并阻止 “慢” 抑制剂的进一步作用。

相似文献

1
Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.纤溶酶系统的研究。II. 血清或血浆对纤溶酶的抑制作用。
J Exp Med. 1958 Jul 1;108(1):53-68. doi: 10.1084/jem.108.1.53.
2
Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.纤溶酶系统的研究。III. 血浆中两种纤溶酶抑制剂的物理性质。
J Exp Med. 1958 Nov 1;108(5):639-49. doi: 10.1084/jem.108.5.639.
3
Kinetics of the inhibition of plasmin in acidified human plasma.酸性人血浆中纤溶酶抑制作用的动力学
Thromb Haemost. 1982 Dec 27;48(3):257-9.
4
Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.在合成三肽底物存在下纤溶酶抑制的动力学。与胰腺胰蛋白酶抑制剂和两种形式的α2-纤溶酶抑制剂的反应。
Biochem J. 1981 Oct 1;199(1):121-7. doi: 10.1042/bj1990121.
5
Kinetic properties of the primary inhibitor of plasmin from human plasma.人血浆纤溶酶原激活物抑制物的动力学特性
Biochem J. 1977 May 1;163(2):389-91. doi: 10.1042/bj1630389.
6
Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma.人血浆纤溶酶原激活物抑制物-1的纯化及反应机制
Biochem J. 1978 Nov 1;175(2):635-41. doi: 10.1042/bj1750635.
7
Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.从锯鳞蝰蛇毒中分离出的纤溶酶缓慢紧密结合抑制剂的功能特性
Biochim Biophys Acta. 2014 Jan;1840(1):153-9. doi: 10.1016/j.bbagen.2013.08.019. Epub 2013 Aug 30.
8
Plasmin inactivation in plasma.血浆中纤溶酶的失活
Thromb Haemost. 1976 Jun 30;35(3):643-50.
9
The behavior of alpha2-plasmin inhibitor in fibrinolytic states.α2-纤溶酶抑制剂在纤溶状态下的行为。
J Clin Invest. 1977 Aug;60(2):361-9. doi: 10.1172/JCI108784.
10
Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitors.人血小板中一种新型快速作用纤溶酶抑制剂的部分纯化及特性鉴定。与已知血浆蛋白酶抑制剂不同的证据。
Biochem J. 1980 Apr 1;187(1):173-80. doi: 10.1042/bj1870173.

引用本文的文献

1
Observations on intrinsic kinin-forming factors in human plasma: the effect of acid, acetone, chloroform, heat and euglobulin separation on kinin formation.人血浆中内源性激肽形成因子的观察:酸、丙酮、氯仿、热和优球蛋白分离对激肽形成的影响。
J Physiol. 1963 May;166(3):496-513. doi: 10.1113/jphysiol.1963.sp007119.
2
EFFECTS OF THROMBIN ON THE POTASSIUM AND ATP CONTENT OF PLATELETS.凝血酶对血小板钾含量和三磷酸腺苷含量的影响。
J Clin Invest. 1964 Nov;43(11):2063-9. doi: 10.1172/JCI105080.
3
THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.止血中的纤维蛋白溶解机制:综述
J Clin Pathol. 1964 Sep;17(5):520-30. doi: 10.1136/jcp.17.5.520.
4
[Antistreptokinase and streptokinase resistance].[抗链激酶与链激酶耐药性]
Klin Wochenschr. 1962 Aug 15;40:813-8. doi: 10.1007/BF01492707.
5
Antifibrinolytic activity in normal pregnancy.正常妊娠中的抗纤溶活性。
J Clin Pathol. 1960 May;13(3):220-3. doi: 10.1136/jcp.13.3.220.
6
Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.纤溶酶系统的研究。III. 血浆中两种纤溶酶抑制剂的物理性质。
J Exp Med. 1958 Nov 1;108(5):639-49. doi: 10.1084/jem.108.5.639.
7
Method of estimating the inhibitory effect of plasma or serum upon urokinase-activated fibrinolysis.评估血浆或血清对尿激酶激活的纤维蛋白溶解抑制作用的方法。
J Clin Pathol. 1966 May;19(3):233-7. doi: 10.1136/jcp.19.3.233.
8
Effect of age, sex, and diurnal variation on the human fibrinolystic system.年龄、性别和昼夜变化对人体纤维蛋白溶解系统的影响。
J Clin Pathol. 1967 May;20(3):223-6. doi: 10.1136/jcp.20.3.223.
9
The intestine as a source of plasminogen activator activity.作为纤溶酶原激活物活性来源的肠道。
Ann Surg. 1971 Nov;174(5):826-9. doi: 10.1097/00000658-197111000-00013.
10
The interaction of alpha2-macroglobulin with proteinases. Binding and inhibition of mammalian collagenases and other metal proteinases.α2-巨球蛋白与蛋白酶的相互作用。对哺乳动物胶原酶及其他金属蛋白酶的结合与抑制作用。
Biochem J. 1974 May;139(2):359-68. doi: 10.1042/bj1390359.

本文引用的文献

1
Studies on a proteolytic enzyme in human plasma; some factors controlling the rate of fibrinolysis.人体血浆中一种蛋白水解酶的研究;控制纤维蛋白溶解速率的一些因素。
J Exp Med. 1948 Oct 1;88(4):401-16. doi: 10.1084/jem.88.4.401.
2
A STUDY OF ANTIFIBRINOLYSIN ACTIVITY IN THE PLASMAS OF VARIOUS ANIMAL SPECIES.不同动物物种血浆中抗纤维蛋白溶酶活性的研究。
J Clin Invest. 1948 Nov;27(6):785-92. doi: 10.1172/JCI102029.
3
Proteolytic enzymes; further studies on protein, polypeptide, and other inhibitors of serum proteinase, leucoproteinase, trypsin, and papain.蛋白水解酶;关于血清蛋白酶、白细胞蛋白酶、胰蛋白酶和木瓜蛋白酶的蛋白质、多肽及其他抑制剂的进一步研究。
J Gen Physiol. 1949 Nov;33(2):103-24. doi: 10.1085/jgp.33.2.103.
4
Studies on the inhibition of proteolytic enzymes by serum. I. The mechanism of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with I131 as a substrate.血清对蛋白水解酶的抑制作用研究。I. 以I131标记的纤维蛋白为底物研究血清对胰蛋白酶、纤溶酶和糜蛋白酶的抑制机制。
J Exp Med. 1952 Jun;95(6):571-91. doi: 10.1084/jem.95.6.571.
5
Studies on the fibrinolysin-antifibrinolysin system in serum. I. Action of the anterior pituitary, adrenal cortex, and spleen.血清中纤维蛋白溶酶-抗纤维蛋白溶酶系统的研究。I. 垂体前叶、肾上腺皮质和脾脏的作用。
J Exp Med. 1951 Jan;93(1):89-97. doi: 10.1084/jem.93.1.89.
6
Serum antiplasmin and plasmin in rheumatoid arthritis.类风湿关节炎中的血清抗纤溶酶和纤溶酶
Ann Rheum Dis. 1955 Jun;14(2):195-7. doi: 10.1136/ard.14.2.195.
7
A proteolytic inhibitor with anticoagulant activity separated from human urine and plasma.从人尿液和血浆中分离出的具有抗凝活性的蛋白水解抑制剂。
J Biol Chem. 1955 Apr;213(2):655-71.
8
Effect of urea and methylamine on plasmin.尿素和甲胺对纤溶酶的作用。
Proc Soc Exp Biol Med. 1957 Dec;96(3):709-11. doi: 10.3181/00379727-96-23584.
9
Factors influencing susceptibility of fibrin and fibrinogen to proteolysis by fibrinolysin.
Arch Biochem Biophys. 1957 Nov;72(1):176-88. doi: 10.1016/0003-9861(57)90184-4.
10
Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.纤溶酶系统的研究。I. 人和动物纤溶酶原的测定;人血清中一种激活剂的测定。
J Exp Med. 1957 Sep 1;106(3):423-37. doi: 10.1084/jem.106.3.423.